Notice of Correction to Specific Areas of Research Interest for PAR-20-168 "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)"
Notice Number:
NOT-NS-21-013

Key Dates

Release Date:

November 5, 2020

Related Announcements

PAR-20-168 - Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

National Center for Complementary and Integrative Health (NCCIH)

Purpose

The purpose of this notice is to inform potential applications of a change to the Specific Areas of Research Interest for PAR-20-168 "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)". The Specific Areas of Research Interest have been modified to remove the IC-specific language for the National Center for Complementary and Integrative Health (NCCIH). This information was erroneously published in the FOA. NCCIH remains signed onto the companion FOA, PAR-20-165 "Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)". This notice is effective for the February 16, 2021 receipt date and subsequent receipt dates. Please see changes to the FOA in Italics below.

Currently Reads:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest

Areas of interest where scientific opportunities exist to meet the objectives of this funding opportunity cut across many disciplines. Proposed research should have relevance to the research priorities of the Institutes, Centers or Offices sponsoring this funding announcement. Specific considerations are listed below

National Center for Complementary and Integrative Health (NCCIH) - NCCIH will accept applications investigating the mechanisms by which complementary and integrative health approaches may improve ME/CFS treatment and/or ME/CFS comorbidity management. The proposed research may include basic and mechanistic studies in cellular systems or model organisms, as well as clinical mechanistic studies to develop improved complementary intervention strategies for ME/CFS and its associated comorbidities. Complementary and integrative approaches may include mind/brain-focused practices (i.e., meditation, hypnosis), body-based approaches (i.e., acupuncture, massage, spinal manipulation), meditative exercise (i.e., yoga, tai chi, qi gong), or natural products (i.e., botanicals, dietary supplements, probiotics), in isolation or in combination with conventional medical treatments. NCCIH will not fund applications examining clinical efficacy and/or effectiveness through this PAR.

National Institute on Alcohol Abuse and Alcoholism (NIAAA) -The mission of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to generate and disseminate fundamental knowledge about the effects of alcohol on health and well-being, and apply that knowledge to improve diagnosis, prevention, and treatment of alcohol-related problems, including alcohol use disorder, across the lifespan.

Modified to Read:

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest

Areas of interest where scientific opportunities exist to meet the objectives of this funding opportunity cut across many disciplines. Proposed research should have relevance to the research priorities of the Institutes, Centers or Offices sponsoring this funding announcement. Specific considerations are listed below

National Institute on Alcohol Abuse and Alcoholism (NIAAA)-The mission of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) is to generate and disseminate fundamental knowledge about the effects of alcohol on health and well-being, and apply that knowledge to improve diagnosis, prevention, and treatment of alcohol-related problems, including alcohol use disorder, across the lifespan.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Vicky Whittemore, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1917
Email: vicky.whittemore@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices